Strides Pharma Science Ltd

Announcement under Regulation 30 (LODR)-Press Release / Media Release

12:54 PM, 30th Jan 2026

Strides continues to deliver exceptional performance with highest ever quarterly EBITDA of Rs.2359 million in Q3 FY26